Your cells use the DNMT1 gene to copy chemical tags on DNA each time a cell divides, helping tissues keep the right genes turned on or off. This gene helps your body maintain stable gene activity over time. When a pathogenic variant disrupts this process, cells can lose that control, which may contribute to inherited nerve and brain conditions. Depending on the variant, people may develop numbness, hearing loss, balance problems, memory changes, or sleep symptoms.
What is a gene?
Genes are sections of DNA that provide cells with instructions for making molecules or regulating processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes occur, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. If you want to go deeper into this subject, you can find more in the LearnHub.
Overview
DNMT1Gene function
What if the gene works
The DNMT1 gene helps cells copy chemical tags on DNA during cell division. This helps cells remember which genes to use or switch off, supporting normal development, brain function, and tissue upkeep.
Risk
What if the gene does not work
Pathogenic variants in the DNMT1 gene can cause rare inherited neurologic conditions with hearing loss, balance problems, numbness, daytime sleepiness or narcolepsy, and sometimes memory decline. Milder and more severe variants may affect when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the DNMT1 gene is currently established for people with a pathogenic variant. The DNMT1 gene is being studied in cancer drug research because it helps control DNA methylation (chemical tags that help switch genes on or off), but this has not led to gene-specific treatment for inherited DNMT1-related conditions.
Conditions associated with DNMT1
Gene function
What if the gene works
Your cells need steady instructions so each new cell knows which genes to use and which to keep quiet. The DNMT1 gene supports this handoff each time a cell divides. It helps preserve the cell’s usual pattern of gene activity over time. This is a key part of how the DNMT1 gene helps maintain normal cell function.
The DNMT1 gene helps copy small chemical tags called methyl groups onto newly made DNA after cell division. This lets new cells inherit the same basic activity settings as the parent cell.
These DNA tags help cells keep some genes quieter and others ready for use at the right time. By preserving these settings, DNMT1 supports organized gene activity in everyday tissues.
When cells divide, they need to remember whether they are skin, blood, nerve, or other cell types. DNMT1 helps hold on to that identity by maintaining the gene use pattern each cell type depends on.
DNMT1 also helps keep repeated stretches of DNA under control so they stay mostly inactive. This supports genome stability, meaning the genetic material remains orderly and works more predictably.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effects and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the DNMT1 gene change the protein’s shape or stability, so it cannot reliably copy chemical tags on DNA during cell division. This shows how variants in the DNMT1 gene affect cell function. Some variants leave partial activity, while more disruptive variants interfere more strongly with folding or DNA binding, which can be linked to earlier onset or broader features in DNMT1-related neurologic conditions.
How variants are linked to conditions
Pathogenic variants in the DNMT1 gene cause two rare inherited neurologic conditions: hereditary sensory and autonomic neuropathy type IE and a syndrome often called cerebellar ataxia, deafness, and narcolepsy. People with DNMT1 gene variants linked to conditions may develop numbness or reduced pain feeling in the feet and hands, hearing loss, balance problems, sleep symptoms, or gradual changes in memory and thinking. These are established gene-disease links, not just small risk effects.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the DNMT1 gene. For many living with a disease-causing DNMT1 change, risk is driven mainly by the genetic change itself, while day-to-day care focuses more on watching for symptoms early and preventing complications.
Inheritance of DNMT1 variants
DNMT1-related conditions are usually inherited in an autosomal dominant pattern. In practical terms, how variants of the DNMT1 gene are inherited means that a person with a disease-causing variant has a 50% chance of passing it on to each child, whether the child is a son or a daughter. A parent who does not carry the variant does not pass that specific DNMT1-related risk on. Family members across several generations can be affected, although symptoms can vary from person to person.
What does my DNMT1 result mean for my family?
A disease-causing change in the DNMT1 gene is usually passed down in families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. That means the result can matter for more than one person in the family, even if symptoms have been mild, different, or have started later in life. Family members may want to talk with their care team about whether this result is relevant to them.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for DNMT1 variants usually uses a blood or saliva sample. A lab reads the DNA sequence of the DNMT1 gene, often as part of a multigene panel or exome test, and checks for variants linked to known DNMT1 related conditions. Results may show a pathogenic variant, a benign variant, or an uncertain finding.
When should I consider getting a genetic test?
Consider genetic testing for the DNMT1 gene if you or close relatives have a rare inherited pattern of worsening numbness, balance problems, hearing loss, memory decline, or unusual daytime sleepiness starting in adulthood. A DNMT1 test can help confirm whether these symptoms are part of a known inherited nerve and brain condition.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains varies by the condition and the specific type of variant. Lifestyle, environment, age, and medical history are among the many factors that also influence how the body functions over time. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences can influence the way a person responds to medication. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes help shape both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the DNMT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in medication response, so questions about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor. Researchers have studied DNMT1 in relation to response to some cancer treatments, but this has not become a standard part of routine prescribing.
History
In recent decades, awareness of this gene’s role has grown. The DNMT1 gene became important as scientists worked out how cells preserve inherited patterns of gene activity from one cell generation to the next. In the late 1980s and early 1990s, researchers identified DNMT1 as a central player in DNA methylation research, helping establish epigenetics as a major field in biology and medicine. From these first observations, research expanded steadily, linking the DNMT1 gene to development, aging, cancer, and later to rare inherited neurologic conditions. Its history is closely tied to the broader shift from viewing genes only as fixed instructions to understanding that chemical marks on DNA also shape health over time.